Metformin Eg

Metformin Hydrochloride, the active ingredient in Metformin EG, is a biguanide presented as an oral dosage form for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus. GNH USA supplies Metformin EG as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is indicated for conditions that involve insulin resistance and elevated blood glucose. - Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes. - Polycystic ovary syndrome (off‑label): may improve insulin sensitivity and menstrual regularity.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools, especially at treatment initiation. - Metallic taste: transient metallic sensation in the mouth. - Abdominal discomfort: cramping or bloating. - Loss of appetite: reduced desire to eat. - Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycemia: when combined with other glucose‑lowering agents. - Pancreatitis: inflammation of the pancreas. - Acute renal failure: especially in patients with pre‑existing kidney disease.

Metformin requires careful monitoring and patient education to minimize risks. - Renal function assessment: evaluate eGFR before initiation and periodically thereafter. - Monitor blood glucose: adjust therapy based on glycemic response. - Assess liver function: avoid use in severe hepatic impairment. - Use caution in elderly: increased susceptibility to lactic acidosis. - Avoid in severe dehydration: ensure adequate hydration. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast media: can precipitate acute renal failure and lactic acidosis. - Cimetidine: may increase metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may reduce renal clearance of metformin. - Beta‑blockers: can mask hypoglycemia symptoms. - ACE inhibitors or ARBs: monitor renal function and potassium. - Other antidiabetic agents: adjust dose to avoid hypoglycemia.